Sichuan Meifeng Chemical Industry Co., Ltd. (SHE:000731)
China · Delayed Price · Currency is CNY 6.86
+0.01 (0.15%)
At close: Feb 6, 2026
SHE:000731 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 4,341 | 4,493 | 4,102 | 4,824 | 4,027 | 2,836 |
Other Revenue | 61.49 | 61.49 | 72.32 | 85.48 | 64.27 | 76.45 |
| 4,403 | 4,554 | 4,174 | 4,910 | 4,091 | 2,912 | |
Revenue Growth (YoY) | 14.68% | 9.10% | -14.98% | 20.01% | 40.47% | -0.57% |
Cost of Revenue | 3,830 | 3,741 | 3,331 | 3,693 | 2,950 | 2,489 |
Gross Profit | 573 | 812.85 | 842.9 | 1,217 | 1,141 | 422.93 |
Selling, General & Admin | 393.63 | 408.66 | 401.34 | 355.56 | 339.88 | 279.94 |
Research & Development | 44.85 | 29.5 | 15.23 | 9.56 | 8.68 | 6.2 |
Other Operating Expenses | 110.48 | 105.19 | 32.65 | 38.43 | 36.31 | 25.35 |
Operating Expenses | 541.2 | 539.79 | 432.71 | 407.1 | 397.78 | 312.29 |
Operating Income | 31.8 | 273.06 | 410.2 | 809.58 | 743.13 | 110.64 |
Interest Expense | -8.25 | -8.32 | -0.34 | -7.81 | -15.37 | -20.22 |
Interest & Investment Income | 82.68 | 97.77 | 59.33 | 61.28 | 41.45 | 18.09 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.85 | 2.41 | -0.97 | -1.43 |
Other Non Operating Income (Expenses) | -2.2 | -0.85 | -0.73 | -0.6 | 0.05 | -0.31 |
EBT Excluding Unusual Items | 104.05 | 361.67 | 467.6 | 864.87 | 768.29 | 106.77 |
Gain (Loss) on Sale of Investments | -17.43 | -17.43 | - | - | - | - |
Gain (Loss) on Sale of Assets | 1.7 | 1.55 | 23.37 | 10.91 | 5.07 | 1.02 |
Asset Writedown | -9.24 | -9.24 | -1.2 | -22.07 | -39.42 | -1.62 |
Other Unusual Items | 5.57 | 5.79 | 8.71 | 12.39 | 6.76 | 5.83 |
Pretax Income | 84.65 | 342.33 | 498.48 | 866.1 | 740.7 | 112.01 |
Income Tax Expense | 12.91 | 57.19 | 88.99 | 130.93 | 81.88 | 13.31 |
Earnings From Continuing Operations | 71.74 | 285.14 | 409.48 | 735.17 | 658.81 | 98.7 |
Minority Interest in Earnings | 3.33 | -13.4 | -26.91 | -113.1 | -89.87 | 5.01 |
Net Income | 75.07 | 271.74 | 382.58 | 622.08 | 568.95 | 103.71 |
Net Income to Common | 75.07 | 271.74 | 382.58 | 622.08 | 568.95 | 103.71 |
Net Income Growth | -69.46% | -28.97% | -38.50% | 9.34% | 448.60% | 20.09% |
Shares Outstanding (Basic) | 557 | 567 | 580 | 586 | 590 | 592 |
Shares Outstanding (Diluted) | 557 | 567 | 580 | 586 | 590 | 592 |
Shares Change (YoY) | -2.45% | -2.27% | -0.91% | -0.74% | -0.26% | 0.02% |
EPS (Basic) | 0.13 | 0.48 | 0.66 | 1.06 | 0.96 | 0.18 |
EPS (Diluted) | 0.13 | 0.48 | 0.66 | 1.06 | 0.96 | 0.18 |
EPS Growth | -68.69% | -27.32% | -37.93% | 10.15% | 450.03% | 20.07% |
Free Cash Flow | -154.83 | 333.59 | 218.02 | 824.84 | 608.38 | 297.26 |
Free Cash Flow Per Share | -0.28 | 0.59 | 0.38 | 1.41 | 1.03 | 0.50 |
Dividend Per Share | 0.270 | 0.270 | 0.170 | 0.170 | 0.170 | - |
Dividend Growth | -0.06% | 58.68% | 0.09% | - | - | - |
Gross Margin | 13.01% | 17.85% | 20.19% | 24.78% | 27.89% | 14.52% |
Operating Margin | 0.72% | 6.00% | 9.83% | 16.49% | 18.16% | 3.80% |
Profit Margin | 1.70% | 5.97% | 9.16% | 12.67% | 13.91% | 3.56% |
Free Cash Flow Margin | -3.52% | 7.32% | 5.22% | 16.80% | 14.87% | 10.21% |
EBITDA | 244.12 | 487.07 | 626.47 | 1,012 | 948.21 | 319.77 |
EBITDA Margin | 5.54% | 10.70% | 15.01% | 20.61% | 23.18% | 10.98% |
D&A For EBITDA | 212.31 | 214.01 | 216.28 | 202.09 | 205.07 | 209.13 |
EBIT | 31.8 | 273.06 | 410.2 | 809.58 | 743.13 | 110.64 |
EBIT Margin | 0.72% | 6.00% | 9.83% | 16.49% | 18.16% | 3.80% |
Effective Tax Rate | 15.25% | 16.71% | 17.85% | 15.12% | 11.05% | 11.88% |
Revenue as Reported | 4,403 | 4,554 | 4,174 | 4,910 | 4,091 | 2,912 |
Advertising Expenses | - | 9.85 | 12.58 | 6.53 | 7.64 | 3.07 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.